Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Bed Bath & Beyond Inc., consolidated cash flow statement

US$ in thousands

12 months ended:	Feb 26, 2022	Feb 27, 2021	Feb 29, 2020	Mar 2, 2019	Mar 3, 2018	Feb 25, 2017
Net earnings (loss)	(559,623)	(150,773)	(613,816)	(137,224)	424,858)	685,108)
Depreciation and amortization	293,626)	340,912)	342,511)	338,825)	313,107)	290,914)
Impairments, including on assets held for sale	36,531)	127,341)	509,226)	509,905)	—)	—)
Stock-based compensation	35,061)	31,594)	45,676)	58,514)	70,510)	71,911)
Excess tax benefit from stock-based compensation	—)	—)	—)	—)	—)	(1,483)
Deferred income taxes	125,711)	148,741)	(145,543)	(104,089)	175,351)	24,878)
Loss on sale of businesses	18,221)	1,062)	—)	—)	—)	—)
(Gain) loss on debt extinguishment	376)	(77,038)	—)	(412)	—)	—)
Loss on sale leaseback transaction	—)	—)	27,357)	—)	—)	—)
Gain on sale of building	—)	—)	—)	(29,690)	—)	—)
Other	(8,298)	(396)	(3,446)	(814)	(69)	(1,032)
Merchandise inventories	(53,339)	64,947)	506,334)	106,928)	176,672)	(38,493)
Other current assets	387,746)	(387,172)	(4,781)	269,186)	(258,853)	(18,464)
Other assets	607)	1,519)	239)	86,495)	(20,790)	(33,260)
(Increase) decrease in assets	335,014)	(320,706)	501,792)	462,609)	(102,971)	(90,217)
Accounts payable	(132,785)	168,556)	(124,206)	(90,657)	13,210)	49,458)
Accrued expenses and other current liabilities	(100,356)	15,538)	61,864)	(77,147)	80,375)	(8,586)
Merchandise credit and gift card liabilities	13,981)	(12,110)	1,154)	16,016)	25,510)	11,390)
Income taxes payable	(11,257)	54,958)	(22,783)	8,360)	(64,941)	(8,307)
Operating lease assets and liabilities, net	(14,162)	(32,813)	(2,899)	—)	—)	—)
Other liabilities	(14,186)	(26,758)	14,054)	(35,918)	(75,251)	17,754)
Increase (decrease) in liabilities	(258,765)	167,371)	(72,816)	(179,346)	(21,097)	61,709)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities	577,477)	418,881)	1,204,757)	1,055,502)	434,831)	356,680)
Net cash provided by operating activities	17,854)	268,108)	590,941)	918,278)	859,689)	1,041,788)
Purchases of held-to-maturity investment securities	(29,997)	—)	(443,500)	(734,424)	(292,500)	—)
Redemption of held-to-maturity investment securities	30,000)	386,500)	545,000)	538,925)	—)	86,240)
Net proceeds from sales of businesses	—)	534,457)	—)	—)	—)	—)
Net proceeds from sales of property	5,000)	—)	—)	—)	—)	—)
Proceeds from sale-leaseback transaction	—)	—)	267,277)	—)	—)	—)
Proceeds from sale of a building	—)	—)	—)	11,183)	—)	—)
Capital expenditures	(354,185)	(183,077)	(277,401)	(325,366)	(375,793)	(373,574)
Investment in unconsolidated joint venture	—)	—)	—)	—)	—)	(3,318)
Payment for acquisitions, net of cash acquired	—)	—)	—)	—)	(6,119)	(201,277)
Net cash (used in) provided by investing activities	(349,182)	737,880)	91,376)	(509,682)	(674,412)	(491,929)
Borrowing of long-term debt	—)	236,400)	—)	—)	—)	—)
Repayments of long-term debt	(11,360)	(457,827)	—)	(4,224)	—)	—)
Repayments of finance leases	(1,033)	—)	—)	—)	—)	—)
Prepayment under share repurchase agreement	—)	(47,550)	—)	—)	—)	—)
Repurchase of common stock, including fees	(589,433)	(332,529)	(99,710)	(148,073)	(252,433)	(547,022)
Excess tax benefit from stock-based compensation	—)	—)	—)	—)	—)	1,483)
Payment of dividends	(749)	(23,108)	(85,482)	(86,287)	(80,877)	(55,612)
Payment of deferred financing fees	(3,443)	(7,690)	—)	—)	(434)	—)
Proceeds from exercise of stock options	—)	—)	2,346)	—)	10,313)	20,424)
Net cash used in financing activities	(606,018)	(632,304)	(182,846)	(238,584)	(323,431)	(580,727)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	1,006)	5,075)	(977)	(7,181)	(4,035)	3,624)
Net increase (decrease) in cash, cash equivalents and restricted cash	(936,340)	378,759)	498,494)	162,831)	(142,189)	(27,244)
Change in cash balances classified as held-for-sale	—)	4,815)	(4,815)	—)	—)	—)
Net increase (decrease) in cash, cash equivalents and restricted cash	(936,340)	383,574)	493,679)	162,831)	(142,189)	(27,244)
Cash, cash equivalents and restricted cash, beginning of period	1,407,224)	1,023,650)	529,971)	367,140)	509,329)	515,573)
Cash, cash equivalents and restricted cash, end of period	470,884)	1,407,224)	1,023,650)	529,971)	367,140)	488,329)

Based on: 10-K (reporting date: 2022-02-26), 10-K (reporting date: 2021-02-27), 10-K (reporting date: 2020-02-29), 10-K (reporting date: 2019-03-02), 10-K (reporting date: 2018-03-03), 10-K (reporting date: 2017-02-25).

Download chart

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Bed Bath & Beyond Inc. net cash provided by operating activities decreased from 2020 to 2021 and from 2021 to 2022.
Net cash (used in) provided by investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Bed Bath & Beyond Inc. net cash (used in) provided by investing activities increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.
Net cash used in financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Bed Bath & Beyond Inc. net cash used in financing activities decreased from 2020 to 2021 but then slightly increased from 2021 to 2022.

Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Cash Flow Statement